Evidence map›Paper›PMID 33841571›Full record

ArticleOncology letters2021

High expression levels of centromere protein A plus upregulation of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway affect chemotherapy response and prognosis in patients with breast cancer.

Songbo Zhang, Yanyan Xie, Ting Tian, Qianru Yang, Yuting Zhou, Juanjuan Qiu, Li Xu, Nan Wen, Qing Lv, Zhenggui Du

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. FBXW7 in breast cancer: mechanism of action and therapeutic potential.Journal of experimental & clinical cancer research : CR · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Songbo ZhangDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Yanyan XieDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Ting TianDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Qianru YangDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Yuting ZhouDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Juanjuan QiuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Li XuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Nan WenDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Qing LvDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Zhenggui DuDepartment of Breast Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Centromere proteins (CENPs) are involved in mitosis, and

Indexed as

breast cancercentromere protein Aneoadjuvant chemotherapyphosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathwayresidual disease

Identifiers

PMID33841571
PMCPMC8020387
OpenAlexW3139240712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.